AKT1 and hepatocellular carcinoma: MCs were stimulated by the hepatitis C virus E2 envelope glycoprotein (HCV-E2), which increased exosomal miRNA-490 levels that affected HCC cells, thereby inhibiting the EGFR/AKT/ERK1/2 pathway, and ultimately suppressing tumor metastasis [70].